University of Health Sciences, Beyoglu Eye Training and Research Hospital, Department of Ophthalmology, Istanbul, Turkey.
Eye (Lond). 2024 Sep;38(13):2522-2529. doi: 10.1038/s41433-024-03064-7. Epub 2024 Apr 12.
To evaluate the 10-year visual, refractive, and tomographic outcomes of epithelium-off accelerated corneal collagen cross-linking (ACCL) in paediatric patients with progressive keratoconus (KC) and to compare the stages in terms of re-progression.
Patients under 18 years of age with progressive KC who underwent ACCL between 2010 and 2012 and completed at least 10 years of follow-up were included in this retrospective study. Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), refractive errors, and corneal tomography parameters were evaluated preoperatively and at 1, 5, and 10 years postoperatively. The effect of stage and age on re-progression was analysed.
The study included 175 eyes of 97 patients (mean age: 14.46 ± 2.17 years). Improvement in UDVA and CDVA was observed in all postoperative periods compared to the preoperative period (each p-value < 0.05). The increase in spherical equivalent (SE), flattening of keratometry values, and decrease in thinnest corneal thickness (TCT) were statistically significant in the tenth year compared to preoperatively (each p-value < 0.05). Re-progression was observed in 16 eyes (9.14%). Haze was observed in 13 eyes (7.43%), 4 of which were permanent. Deep anterior lamellar keratoplasty was performed in 3 eyes (1.7%) and a second ACCL in 3 eyes (1.7%).
ACCL is an effective and safe long-term strategy to prevent progression of KC in paediatric patients. In the light of this study with a 10-year follow-up re-progression rate of 9.14%, long-term follow-up of patients after ACCL for possible re-progression and the need for re-CCL or keratoplasty may be recommended.
评估上皮下加速角膜胶原交联(ACCL)治疗进展性圆锥角膜(KC)儿童患者的 10 年视力、屈光和断层成像结果,并比较进展程度的再进展情况。
本回顾性研究纳入了 2010 年至 2012 年间接受 ACCL 治疗且至少随访 10 年的年龄在 18 岁以下、进展性 KC 患者。在术前和术后 1、5 和 10 年分别评估未矫正远视力(UDVA)、矫正远视力(CDVA)、屈光不正和角膜断层参数。分析了阶段和年龄对再进展的影响。
该研究共纳入了 97 例患者的 175 只眼(平均年龄:14.46±2.17 岁)。与术前相比,所有术后期间 UDVA 和 CDVA 均有所改善(p 值均<0.05)。与术前相比,第 10 年时球镜等效(SE)增加、角膜曲率值变平、最薄角膜厚度(TCT)减少,差异有统计学意义(p 值均<0.05)。16 只眼(9.14%)出现再进展。13 只眼(7.43%)出现混浊,其中 4 只为永久性混浊。3 只眼(1.7%)行深板层角膜移植术,3 只眼(1.7%)行二次 ACCL。
ACCL 是预防儿童患者 KC 进展的一种有效且安全的长期策略。根据本研究 10 年随访的再进展率为 9.14%,建议对接受 ACCL 治疗的患者进行长期随访,以预防可能的再进展,并考虑再次行 CCL 或角膜移植术的必要性。